Year |
Citation |
Score |
2014 |
Bisgin H, Liu Z, Fang H, Kelly R, Xu X, Tong W. A phenome-guided drug repositioning through a latent variable model. Bmc Bioinformatics. 15: 267. PMID 25103881 DOI: 10.1186/1471-2105-15-267 |
0.329 |
|
2013 |
Chen M, Hong H, Fang H, Kelly R, Zhou G, Borlak J, Tong W. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs. Toxicological Sciences : An Official Journal of the Society of Toxicology. 136: 242-9. PMID 23997115 DOI: 10.1093/Toxsci/Kft189 |
0.325 |
|
2013 |
Chen M, Zhang J, Wang Y, Liu Z, Kelly R, Zhou G, Fang H, Borlak J, Tong W. The liver toxicity knowledge base: a systems approach to a complex end point. Clinical Pharmacology and Therapeutics. 93: 409-12. PMID 23486446 DOI: 10.1038/Clpt.2013.16 |
0.327 |
|
2012 |
Bisgin H, Liu Z, Kelly R, Fang H, Xu X, Tong W. Investigating drug repositioning opportunities in FDA drug labels through topic modeling. Bmc Bioinformatics. 13: S6. PMID 23046522 DOI: 10.1186/1471-2105-13-S15-S6 |
0.307 |
|
2011 |
Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W. Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). Plos Computational Biology. 7: e1002310. PMID 22194678 DOI: 10.1371/Journal.Pcbi.1002310 |
0.335 |
|
2010 |
Kelly RJ, Smith JA, Kardia SL. Providing context and interpretability to genetic association analysis results using the KGraph. Advances in Genetics. 72: 181-93. PMID 21029853 DOI: 10.1016/B978-0-12-380862-2.00008-4 |
0.301 |
|
2008 |
Kardia SL, Kelly RJ, Keddache MA, Aronow BJ, Grabowski GA, Hahn HS, Case KL, Wagoner LE, Dorn GW, Liggett SB. Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival. Bmc Medical Genetics. 9: 93. PMID 18947427 DOI: 10.1186/1471-2350-9-93 |
0.303 |
|
2008 |
Smith JA, Arnett DK, Kelly RJ, Ordovas JM, Sun YV, Hopkins PN, Hixson JE, Straka RJ, Peacock JM, Kardia SL. The genetic architecture of fasting plasma triglyceride response to fenofibrate treatment. European Journal of Human Genetics : Ejhg. 16: 603-13. PMID 18212815 DOI: 10.1038/Sj.Ejhg.5202003 |
0.316 |
|
Show low-probability matches. |